# Individualized Blood Pressure Management in Patients Undergoing Cardiac Surgery

> **NCT03784690** · NA · WITHDRAWN · sponsor: **Meshalkin Research Institute of Pathology of Circulation**

## Conditions studied

- Cardiac Surgery

## Interventions

- **OTHER:** Individualized intraoperative BP management
- **OTHER:** Standard intraoperative BP management

## Key facts

- **NCT ID:** NCT03784690
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-21
- **Primary completion:** 2020-03-10
- **Final completion:** 2020-04-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** According to new guidelines, the use of vasopressors to force the MAP during CPB at values higher than 80 mmHg is not recommended.
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03784690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03784690, "Individualized Blood Pressure Management in Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03784690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*